Based in Ottawa, Canada, Genomadix Inc. is a pioneer in real-time qPCR point of need technology, dedicated to the highest level of customer satisfaction, quality, and support, maintaining ISO 13485 medical device development and manufacturing standards certification. The Genomadix Cube is a real-time polymerase chain reaction (PCR) molecular diagnostic instrument capable of performing tests for precision medicine genotyping and environmental targets on a sample-to-result platform. The portable size, ease of use, and on-demand processing capability enables users to generate time-critical results in approximately one hour. The Cube platform includes tests for: - Rapid CYP2C19 Genotyping (FDA 510(k)-Cleared and CE Marked) - Environmental water testing for Legionella pneumophila - Apolipoprotein E (ApoE) RUO genotyping The Cube platform is also available as an open platform called CubeX that can be used to run any qPCR tests for research use only. Genomadix’s technology for the cube includes over 3 million hours of research and development, 11 patents and 30 peer-reviewed scientific publications.